Company intelligence / Profile preview
NanoNewron
Not explicitly stated; likely Europe based on language and style but not confirmed.pmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NanoNewron is developing a patented platform technology, NewroBus™, which uses single-chain nanobodies targeting transferrin receptor 1 to shuttle biologics across the blood-brain barrier. Their lead candidate, NN-841—a heterotrimer of their proprietary nanobody and two TNF-alpha inhibitors—has demonstrated high brain penetration and potent TNF-alpha inhibition in animal models with excellent tolerability. No human clinical data reported yet.
- Therapeutic areas
- Neurology
- Modalities
- Nanobody therapyBiologicAntibody (specifically single-chain nanobodies)Fusion protein (heterotrimeric constructs)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.
Beyond the preview
Go deeper on NanoNewron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoNewron.